Infantile hemangiomas (IHs) are the most common vascular tumors in infants, appearing in early infancy and ultimately regressing with time. Clinical presentation may vary, with a minority of lesions causing impairment of vital function (e.g., respiratory or visual obstruction), permanent scarring, and/or disfigurement. The pathogenesis of IH is complex and poorly understood. Risk factors implicated in their development include preterm birth and placental anomalies. IH presents a myriad of clinical challenges, including correct diagnosis and whether or not to pursue treatment. This article is a review of the current literature regarding pathogenesis, clinical presentation, treatment, and prognosis of IH. Birth Defects Research 109:809–815, 2017. © 2017 Wiley Periodicals, Inc.
CITATION STYLE
Smith, C. J. F., Friedlander, S. F., Guma, M., Kavanaugh, A., & Chambers, C. D. (2017, July 3). Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth Defects Research. John Wiley and Sons Inc. https://doi.org/10.1002/bdr2.1023
Mendeley helps you to discover research relevant for your work.